Ready to learn?
Take the first step toward achieving your educational goals. Whether you’re preparing for exams or expanding your knowledge, getting started is just a click away. Join us today and unlock your full potential
Utkarsh Classes
Admission office
Above Arora Namkeen
Jalori Gate circle,
Jodhpur (Raj.), 342005
support@utkarsh.com
+91-9116691119, +91-9829213213
Support
Learning Resources
Rajasthan Govt Exams
Central Govt Exams
Civil Services Exams
Nursing Exams
School Tuitions
Other State Govt Exams
Agriculture Exams
College Entrance Exams
Miscellaneous Exams
© 2026 Utkarsh Classes & Edutech Pvt. Ltd. All Rights Reserved
Home
National Current Affairs
Health and Disease
Shivraj Singh Chouhan to Launch India’s First H5N1 Bird Flu Vaccine
Add as a preferred source on Google
Union Minister Shivraj Singh Chouhan dedicates India’s first indigenous H5N1 (Clade 2.3.2.1a) HPAI chicken vaccine, developed by ICAR-NIHSAD Bhopal, on 20 November 2026.
Updated: 18 Nov 2026
4 Min Read

Union Minister of Agriculture and Farmers Welfare and Rural Development Shri Shivraj Singh Chouhan will dedicate India’s first indigenous Inactivated H5N1 (Clade 2.3.2.1a) Highly Pathogenic Avian Influenza (HPAI) Vaccine for Chickens to the nation on 20 November, 2026. The dedication ceremony will take place at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, Madhya Pradesh.
Scientists at ICAR-NIHSAD, Bhopal, developed this breakthrough vaccine entirely within India. It is the country’s first dedicated veterinary vaccine targeting the Clade 2.3.2.1a strain of the H5N1 bird flu virus. Currently, no specific commercial vaccine exists against this particular strain, making this scientific milestone vital for protecting Indian poultry farms and rural livelihoods.
|
Particulars |
Official Details |
|
Vaccine Name |
Inactivated H5N1 (Clade 2.3.2.1a) Highly Pathogenic Avian Influenza (HPAI) Vaccine for Chickens |
|
Developing Institution |
ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal |
|
Dedication Date |
20 November, 2026 |
|
Dedicating Dignitary |
Shivraj Singh Chouhan (Union Minister of Agriculture & Farmers Welfare and Rural Development) |
|
Target Viral Strain |
H5N1 HPAI Virus — Clade 2.3.2.1a |
|
Outbreak History in India |
Over 500 combined outbreaks of H5N1 and H5N8 recorded since 2006 |
|
Global Human Toll (WHO) |
1,003 human cases and 479 deaths across 25 countries since 2003 |
Highly Pathogenic Avian Influenza (HPAI)—commonly known as bird flu—poses a severe threat to poultry farming. Outbreaks frequently cause nearly 100 per cent mortality among infected flocks. When the virus strikes, authorities must enforce large-scale culling and trade restrictions, triggering devastating financial losses for poultry farmers.
Beyond poultry economics, H5N1 remains a critical global public health concern. According to the World Health Organization (WHO), countries worldwide have reported 1,003 human cases of H5N1 avian influenza—including 479 deaths—across 25 nations, including India, since 2003.
Scientific investigations reveal that the Clade 2.3.2.1a strain drives the vast majority of bird flu outbreaks among chickens in India. Recently, researchers also detected Clade 2.3.2.1a infections across several other animal species, including mammals, alongside three human cases. Controlling the virus directly at its poultry source stops transmission to mammals and humans while safeguarding farmers' incomes.
Until now, poultry farmers lacked a commercial vaccine tailored specifically to the Clade 2.3.2.1a H5N1 strains circulating in India. By developing an indigenous inactivated vaccine, ICAR-NIHSAD, Bhopal, provides India with a homegrown biological shield.
About the author
Latest Current Affairs
Frequently asked questions

Visit Utkarsh Classes Offline Centre Near You.